海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
- Renal Impairment;Renal Impairment;Renal Impairment;Renal Impairment
- Bulgaria, Germany, Romania, South Africa
- 2015-03-20
Not recruiting
- Phase I Study of GW856553 (Losmapimod)
- Acute Coronary Syndrome;Acute Coronary Syndrome;Acute Coronary Syndrome;Acute Coronary Syndrome
- Australia
- 2012-07-12
Not Recruiting
- Safety evaluation of Uniform Particle NovaSil in Children (Phase I study)
- Injury, Occupational Diseases, Poisoning Paediatrics Aflatoxin exposure;Injury, Occupational Diseases, Poisoning;Paediatrics;Aflatoxin exposure
- Ghana
- 2013-11-22
Not recruiting
- An open label, phase I study to determine the pharmacokinetic, safety and tolerability profiles of oxymorphone delivered from multiple applications of a transdermal oxymorphone patch.
- To promote pain relief, tested in healthy volunteers.
- Australia
- 2013-08-23
Not recruiting
- Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects
- Toxoplasmosis
- Australia
- 2017-08-21
Not recruiting
- Phase 1 clinical trial evaluating whether probiotic supplementation prevents chemotherapy-induced diarrhoea and other intestinal adverse effects in cancer patients.
- Cancer;Diarrhoea;Neutropenia
- Australia
- 2018-05-31
Not recruiting
- Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies
- Advanced Cancer;Advanced Cancer;Advanced Cancer;Advanced Cancer
- Australia, Estonia
- 2008-02-26
Not recruiting
- A Phase I Study of LBH589 in Children With Refractory Solid and Central Nervous System (CNS) Tumours
- Relapsed/refractory solid tumours including CNS tumours
- Australia
- 2009-11-12
Not recruiting
- Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers
- Cancer;Cancer;Cancer;Cancer
- Australia
- 2009-10-15
Not recruiting
- A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors
- Cancer;Cancer;Cancer;Cancer
- Australia, United States
- 2009-04-09